{
    "2020-03-13": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Product Development",
                        "FDA Updates"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Coronavirus Drug Development Efforts Pick Up Amid Sell-Off",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Drug Development",
                        "Sell-Off"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches Antivirals",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Biotechs",
                        "Giapreza",
                        "Antivirals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Is Eli Lilly and Company (LLY) A Good Stock To Buy?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}